Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Neurology Physician in Laguna Niguel, CA
NPI: 1467482216Primary Employer
MS Center of Southern California
mscenterofcalifornia.com
HQ Phone
Get M.D. Daniel's Phone Numberphone_androidMobile
Get M.D. Daniel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2003 - 2027
University of Southern California/LAC+USC Medical Center
Fellowship • Neuroimmunology & Multiple Sclerosis
2004 - 2006
Kaiser Permanente Southern California (Los Angeles)
Residency • Neurology
2000 - 2004
American University of the Caribbean School of Medicine
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 120 | 464 |
| 2 | 95874Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | 15 | 74 |
| 3 | 64644Injection of chemical for destruction of nerve muscles on arm or leg, 5 or more muscles | 15 | 74 |
| 4 | 96365Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 12 | 48 |
| 5 | J0588Injection, incobotulinumtoxin a, 1 unit | 11 | 16,900 |
Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis.
Authors: Bianca Weinstock Guttman, Pavle Repovic, Mark Gudesblatt, Bhupendra Khatri, Mariko Kita, Sherrill Loring, Ben Thrower, Jeffrey Greenstein
Publication Date: 2019-11-14
Authors: Theodore Chan
Journal: J Manag Care Pharm
Authors: Gerard Francisco, Alberto Esquenazi, Alberto Esquenazi
Journal: PM R
Publication Date: 2016-09-24
Lead Sponsor: MedDay Pharmaceuticals SA
Intervention / Treatment: DRUG: PLACEBO, DRUG: MD1003 100mg capsule
Lead Sponsor: Oregon Health and Science University
Collaborators: University of Southern California, Forest Laboratories, University of Texas Southwestern Medical Center, MS-Hub Seattle
Intervention / Treatment: DRUG: Memantine
Lead Sponsor: Sanofi
Intervention / Treatment: DRUG: Placebo, DRUG: Tolebrutinib